SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 18, 2005
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction
|(Commission File Number)|| |
|321 Harrison Avenue, Boston, Massachusetts||02118|
|(Address of Principal Executive Offices)||(Zip Code)|
Registrants telephone number, including area code (617) 482-2700
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 2.02 Results of Operations and Financial Condition.
On October 18, 2005, Teradyne, Inc. (the Company) issued a press release regarding its financial results for the quarter ended October 2, 2005. The Companys press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
The exhibit listed below and in the accompanying Exhibit Index is furnished as part of this Current Report on Form 8-K.
|99.1*||Press Release dated October 18, 2005, of Teradyne, Inc.|
|*||Furnished, not filed.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: October 18, 2005
|By:||/s/ Gregory R. Beecher|
|Name:||Gregory R. Beecher|
|Title:||V.P. & Chief Financial Officer|
|99.1||Press Release dated October 18, 2005 of Teradyne, Inc.|